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We have previously described that silencing of the mitochondrial protein OPA1 enhances mitochondrial
Ca2+ signaling and aldosterone production in H295R adrenocortical cells. Since extramitochondrial OPA1
(emOPA1) was reported to facilitate cAMP-induced lipolysis, we hypothesized that emOPA1, via the
enhanced hydrolysis of cholesterol esters, augments aldosterone production in H295R cells. A few
OPA1 immunopositive spots were detected in 40% of the cells. In cell fractionation studies OPA1/COX
IV (mitochondrial marker) ratio in the post-mitochondrial fractions was an order of magnitude higher
than that in the mitochondrial fraction. The ratio of long to short OPA1 isoforms was lower in post-mito-
chondrial than in mitochondrial fractions. Knockdown of OPA1 failed to reduce db-cAMP-induced phos-
phorylation of hormone-sensitive lipase (HSL), Ca2+ signaling and aldosterone secretion. In conclusion,
OPA1 could be detected in the post-mitochondrial fractions, nevertheless, OPA1 did not interfere with
the cAMP – PKA – HSL mediated activation of aldosterone secretion.
 2013 Published by Elsevier Ireland Ltd.39
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741. Introduction
The precursor of corticosteroids is cholesterol. Cholesterol may
be synthetized within the endoplasmic reticulum or taken up from
plasma lipoproteins. Cholesterol esters, taken up by endocytosis of
receptor-bound LDL particles, are hydrolyzed in the endoplasmic
reticulum. More important for steroid biosynthesis is HDL-trans-
ported esteriﬁed cholesterol, taken up by scavenger receptor B1
(Rone et al., 2009) and hydrolyzed by cholesterol esterase (Rodri-
gueza et al., 1999). The esterase was recently found to be identical
with the HSL of lipocytes (Kraemer et al., 2004). Following reeste-
riﬁcation cholesterol accumulates in special, phospholipid layer
bounded droplets. Rapid increase of cortisol secretion during stress
or increased aldosterone secretion during acute ﬂuid loss requires
the rapid mobilization of cholesterol stored in these lipid droplets
(Hattangady et al., 2011; Vinson et al., 1992). Deesteriﬁcation is
performed again by HSL (Kraemer et al., 2004).75
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85The dual action of HSL is under hormonal control. ACTH,
through cAMP-PKA, phosphorylates and thus activates the enzyme
(Hirsch and Rosen, 1984; Holm et al., 2000; Kraemer et al., 2004;
Trzeciak and Boyd, 1974) and also induces its expression (Grann-
eman and Moore, 2008; Holysz et al., 2011). Calcium ion, the sec-
ond messenger of angiotensin II, acts via CaMKII to activate
(Cherradi et al., 1998) and through p42/p44 mitogen-activated
protein kinase (Cherradi et al., 2003) to increase the expression
of HSL.
Transfer of the released cholesterol to the side-chain cleaving
enzyme cytochrome P450scc (CYP11A1), located in the IMM, is car-
ried out by a complex of cytosolic and mitochondrial proteins
(Rone et al., 2009). At least two components of this complex, StAR
and the translocator protein TSPO (previously named as peripheral
benzodiazepine receptor) are phosphorylated and induced by PKA
(Dyson et al., 2008; Fleury et al., 2004; Manna et al., 2002; Midzak
et al., 2011). Although Ca2+ - mobilizing agonists (through Ca2+ and
protein kinase C) were also reported to phosphorylate StAR (Betan-
court-Calle et al., 2001; Cherradi et al., 1998) their major effect is
the induction of StAR expression (Clark et al., 1995; Lucki et al.,
2012; Martin et al., 2008).
In adipocytes activated PKA phosphorylates and brings about
translocation of the cytosolic HSL to the membrane fraction (Hirsch
and Rosen, 1984). This translocation requires the 62-kDa protein
perilipin 1 (Plin 1) located on the surface of lipid droplets (Green-
berg et al., 1991; Miyoshi et al., 2006). It is assumed that non-phos-
phorylated Plin 1 inhibits the access of phosphorylated HSL to its
substrate (Brasaemle et al., 2009; Sztalryd et al., 2003; Tansey(2013),
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3 August 2013et al., 2001; Zhang et al., 2003). Albeit PKA-mediated phosphoryla-
tion of Plin is not required for the translocation, phosphorylation is
essential for hormone-induced lipolysis (Miyoshi et al., 2006). It is
assumed that phosphorylation of Plin 1 permits the activation of
adipocyte triglyceride lipase (Granneman et al., 2011; Subramani-
an et al., 2004; Yamaguchi et al., 2007) which provides diacylglyc-
erol for further hydrolysis by HSL (Zimmermann et al., 2004).
A recently described factor participating in hormonally-induced
lipolysis is Optic Atrophy 1 (OPA1). OPA1 (and its ortholog Mgm1p
in yeast) has been known as a dynamin-related mitochondrial
GTPase protein. In cooperation with Mitofusin 1 (Mfn 1) OPA1 in-
duces mitochondrial fusion and its mutation is the most common
cause of type 1 autosomal dominant optic atrophy (Belenguer
and Pellegrini, 2012; Cipolat et al., 2004). Unexpectedly, OPA1
has been detected in lipocytes on the surface of Plin-coated lipid
droplets (Pidoux et al., 2011). Immunocytochemical and immuno-
precipitation studies showed that PKA binds to the Plin-associated
OPA1 and the formation of this complex results in Plin phosphor-
ylation and lipolysis. OPA1 contains an A-kinase binding domain
and thus it may function as an AKAP. In fractionation studies the
amount of OPA1 in the lipid droplet fraction far exceeded that in
the mitochondrial fraction. Based on these observations a signiﬁ-
cant role has been attributed to OPA1 in the hormonal control of
lipolysis, assuming that OPA1 potentiates the phosphorylation of
Plin 1 by PKA and thus makes further steps possible (presumably
the activation of adipocyte triglyceride lipase) (Greenberg et al.,
2011; Pidoux et al., 2011). We are not aware of studies on emOPA1
in cell types other than adipocyte.
In humans OPA1 has eight mRNA isoforms and the expressed
proteins can be separated in ﬁve bands between 96 and 84 kDa
in Western blots. The two higher-molecular mass bands, the so-
called long isoforms are mixture of isoforms 1, 2, 4 and 7 whereas
the three short isoforms contain proteolytic products of the long
ones and also isoforms 3, 5, 6 and 8. The long isoforms are attached
to the IMM, the soluble short ones were found in the IMS partly
associated to the OMM (Delettre et al., 2000; Lenaers et al., 2009;
Liesa et al., 2009). OPA1 controls the diameter of the junction of
cristae (Scorrano et al., 2002) and thus modiﬁes the molecular dif-
fusion between the lumen of the cristae and the IMS (Frey et al.,
2002) and/or between the boundary (inner) and crista membrane
(Sukhorukov and Bereiter-Hahn, 2009). Knockdown of OPA1 inFig. 1. Cholesterol supply to mitochondria in adrenal glomerulosa cells. The presence
marks.
Please cite this article in press as: Fülöp, L., et al. Extramitochondrial OPA1 a
http://dx.doi.org/10.1016/j.mce.2013.07.021H295R human adrenocortical cells, probably due to the altered dif-
fusion conditions, facilitates the transfer of cytosolic Ca2+ signal
into the mitochondrial matrix (Fülöp et al., 2011) resulting in en-
hanced aldosterone production (Spät et al., 2012).
In addition to HSL another factor participating in lipolysis, Pli-
n1a (formerly Plin A) has also been detected in Y-1 murine adreno-
cortical cells (Servetnick et al., 1995). Other Plin isoforms,
predominantly Plin1c (formerly Plin C), could also be detected fol-
lowing incubation with cholesterol (Hsieh et al., 2012). Impor-
tantly, Plin1a was phosphorylated in a cAMP-dependent manner
(Servetnick et al., 1995). The data showing that identical molecules
participate in the control of lipid metabolism in adipocytes and
adrenocortical cells prompted us to examine whether OPA1, func-
tioning as an AKAP, is a feasible candidate for regulating cAMP-in-
duced steroid secretion. The veriﬁed and hypothetical mechanisms
supplying cholesterol to mitochondria are shown in Fig. 1. We pre-
sumed that silencing of OPA1, if functioning as an AKAP in the
extramitochondrial space, would reduce PKA-mediated steroid
production to a greater extent than PKA-independent response.
Our observations indicate that OPA1 is present in the extramito-
chondrial compartment in H295R cells but the role of emOPA1 in
the control of steroid secretion could not be demonstrated.2. Materials and methods
2.1. Materials
NIH-H295R cells (ATCC, CRL-2128) were purchased from LGC
Standards Gmbh, Wesel, Germany. siRNA and silencing RNA prod-
ucts as well as OPTI-MEM, Lipofectamine 2000, Fluo-4 and Mito-
Tracker Deep Red were purchased from Life Technologies
(Paisley, UK).
CholEsteryl-BODIPY FL C12 (C-3927MP) was from Life Technol-
ogies (San Diego, CA, USA), UltroSer G was from Bio Sepra (Cer-
gy-Saint-Christophe, France). 2mt-eGFP (eGFP fused with a
doublet of human cytochrome c oxidase target sequence) was a gift
from Dr. B. Enyedi (Budapest, Hungary). Coat-A-Count RIA kit was
purchased from Siemens Health Care Diagnostics (Los Angeles, CA).
Primary antibodies were purchased as follows: anti-OPA1
monoclonal antibody (612606): BD Bioscience (Franklin Lakes,and actions of extramitochondrial OPA1 are hypothetical as shown with question
nd adrenocortical function. Molecular and Cellular Endocrinology (2013),
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3 August 2013NJ); anti-cytochrome oxidase IV (COX IV) monoclonal antibody
(SC-58348) and polyclonal antibody (D-20; SC-693599, anti-cyto-
chrome c rabbit polyclonal antibody (SC-7159) and HSL monoclo-
nal antibody (sc-74489): Santa Cruz Biotechnology (Santa Cruz,
CA); anti-protein disulﬁde isomerase monoclonal antibody
(ab2792): Abcam (Cambridge, UK); anti-MFN1 mouse polyclonal
antibody (H00055669-M04): Abnova (Taipei, Taiwan) and anti-
phospho-HSL rabbit polyclonal antibody (PA5-17488): Thermo Sci-
entiﬁc (Rockford, IL). Secondary antibodies were as follows: for
Western blots: anti-mouse immunoglobulin-HRP: GE Healthcare
(Amersham, UK), anti-rabbit immunoglobulin-HRP: GE Health Care
Diagnostic (Deerﬁeld, IL) and donkey anti-goat IgG-HRP: Santa
Cruz Biotechnology; for immunocytochemistry: Alexa Fluor 568
goat anti-mouse IgG (A 11004) and Alexa Fluor 633 goat anti-rab-
bit IgG (A 21070): Life Technologies.239
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2562.2. Cell culture and transfection
H295R cells were grown in DMEM/Ham’s F12 (1:1 v/v) contain-
ing 1% ITS+, 2% UltroSer G, 100 U/ml penicillin and 100 lg/ml strep-
tomycin. Passage numbers 4–20 were used. For transfection with
2mt-eGFP (for confocal microscopic examination) we used 0.4 lg
plasmid DNA with 0.4 ll Lipofectamine 2000 in 220 ll OPTI-
MEM medium. The transfection was performed on day 2 and re-
peated on day 3. The cells were ﬁxed one day later. For transfection
with scrambled RNA or siRNA (for the examination of HSL phos-
phorylation and in aldosterone experiments) the cells were elec-
troporated before plating, using the Neon electroporator and kit
(MPK10025) of Life Technologies. For measuring aldosterone pro-
duction the cells were stimulated with appropriate agonists on
day 4 (2-h stimulation) or on days 3 and 4 (24-h stimulation).
For confocal measurement of [Ca2+] the cells were transfected with
siRNA on day 2, applying RNAiMax.257
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2852.3. Immunocytochemistry
For immunocytochemistry about 5  104 cells were plated onto
glass coverslips. Staining with 2 lM CholEsteryl-BODIPY FL C12 for
one day was carried out at 37 C in CO2 incubator. The cells were
ﬁxed in 4% paraformaldehyde (in PBS, pH 7.4) for 10 min at room
temperature and then rinsed. For quenching autoﬂuorescence the
samples were incubated in 100 mM glycine for 45 min and then
washed twice. Permeabilisation was performed with a mixture of
5% milk powder, 0.2% Triton X-100, at room temperature for
15 min. Blocking with 5% milk powder, 1% FCS and 0.1% Triton X-
100 lasted for 1 h. Incubation with primary antibodies (1:50) in
blocking buffer at 4 C lasted overnight. The secondary antibody
(usually at a dilution of 1:100, but for cytochrome c staining Alexa
Fluor 633 was diluted 500-fold) was applied in blocking buffer
after repeated washings. Further six washings were followed by
mounting with MOWIOL.
Microscopic examination was undertaken with a Zeiss LSM710
confocal laser scanning microscope, operated with ZEN 9.0 soft-
ware. The cells were examined with a 63/1.4 oil immersion
objective (Plan-Apochromat, Zeiss). As an exception, for cells trans-
fected with 2mt-eGFP a 40/1.2 water immersion objective (C-
Apochromat, Zeiss) was used. Imaging was performed in multi-
track mode. The optical slice was 1 lm. The measured cross-over
of Alexa 568 into the emission range of Alexa 633 has been sub-
tracted applying Image J 1.43u software. The imaging parameters
are shown in Supplementary Table 1. Images were deconvoluted
with Image J plug-in ‘‘Iterative Deconvolve 3D’’ (Version 5.2). Addi-
tional lambda scan imaging was performed with simultaneously
acquired emission spectrum of each ﬂuorophore, using array
detector.Please cite this article in press as: Fülöp, L., et al. Extramitochondrial OPA1 a
http://dx.doi.org/10.1016/j.mce.2013.07.0212.4. Cell fractionation
2.4.1. Homogenization and mitochondrial fractions
Cell fractionation was carried out with three separate sub-
clones, ﬁrst with 3  107 and then with 108 cells. Three days after
passage the cells were homogenized using microscopic control. A
combination of about 40 strokes in a glass-Teﬂon Potter-Elvijem
homogenizer and 40 aspirations and ejections through a 26 guage
needle were applied in a homogenization buffer (50 ll/106 cells)
(containing 250 sucrose mM, 10 mM Tris.HCl (pH 7.4), 1 mM EDTA,
10 mMNaF, 1 mM benzamidine, 0.075 U/ml Aprotinin, 1 mM PMSF
and 1:100 Sigma Mammalian Protease Inhibitor Cocktail) com-
pleted with an equal volume of distilled water (total = 1 volume).
Following the homogenization the buffer was made isosmotic with
the addition of 0.4 volume of a 2.25-fold concentrated homogeni-
zation buffer. The homogenate was centrifuged in a swing-out ro-
tor at 1000 gmax for 10 min. The nuclear pellet was discarded; the
supernatant was centrifuged in an Eppendorf fuge (12,000 gmax) for
15 min. To obtain mitochondrial fraction the pellets were pooled,
twice resuspended and recentrifuged in homogenation buffer.
The resulting pellet was shaken for 30 min at 37 C in an extracting
solution (Servetnick et al., 1995) and ﬁnally spun in the Eppendorf
fuge for 15 min. The supernatant, sampled for protein determina-
tion, was completed with sample buffer (see below) and stored
at 20 C for analysis on Western blot.
2.4.2. Cytosolic fraction
The pooled supernatants obtained after the ﬁrst centrifugation
in Eppendorf fuge were transferred into ultracentrifuge tubes and
centrifuged in a ﬁxed-angle rotor at 31,000 gmax for 25 min. No pel-
let was obtained, a sample from the middle height of the tube was
withdrawn for protein determination and another aliquot was
completed with sample buffer and stored at 20 C for analysis
on Western blot.
2.4.3. Fat cake fraction
A cloudy aggregate ﬂoating in the uppermost layer of the cyto-
solic fraction and hence termed fat cake, was aspirated and ex-
tracted with 2 vol of extracting solution and processed as done
for mitochondria (see above). Samples were withdrawn from the
lower phase for protein and Western blot analysis as described
for the mitochondrial fraction. Since COX IV concentration of these
samples could not be reliably measured, those measured in the
cytosolic fraction were used in the calculation of OPA1/COX IV ra-
tio. The sample buffer applied for the different cell fractions con-
tained the following components, yielding a ﬁnal concentration
given in brackets: Tris.HCl (40 mM), glycerol (10%), b-mercap-
toethanol (5%), bromophenolblue (0.005%) and SDS (2%) (pH 7.0).
All the above steps, with exceptions as speciﬁed, were per-
formed at 4 C.
2.5. Electrophoresis and immunoblotting
The cells were suspended in ice-cold lysis buffer (100 mM NaCl,
30 mM HEPES pH 7.4, 0.2% Triton X-100, 20 mM NaF, 2.5 mM Na-
EGTA, 2.5 mM Na-EDTA, 10 mM benzamidine, 0.075 U/ml Aproti-
nin, 1:100 Sigma Mammalian Protease Inhibitor Cocktail, 1 mM so-
dium-vanadate, 10 mM PMSF). The insoluble fraction was removed
with centrifugation. The supernatant was completed with sample
buffer to give a ﬁnal concentration as described above (Section
2.4).
Lysed cell samples as well as samples of subcellular fractions
were run on 10% (but for HSL 8%) SDS–PAGE and transferred onto
nitrocellulose membrane (pore size: 0.45 lm). After blocking, the
primary antibodies were applied as follows: cytochrome c
(1:200), COX IV (1:200), HSL (1:1000), phospho-HSL (1:500),nd adrenocortical function. Molecular and Cellular Endocrinology (2013),
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3 August 2013Mfn1 (1:500), OPA1 (1:500), PDI (1:3000). Anti-mouse and anti-
rabbit secondary antibodies were applied at a dilution of 1:5000
and 1:2500, respectively. For quantitative estimation of OPA1
and COX IV a dilution series of the mitochondrial samples were
run parallel with samples of the two supramitochondrial fractions.
For quantitative estimation of OPA1 and COX IV a dilution series of
the mitochondrial samples were run parallel with samples of the
two supramitochondrial fractions. Cytosolic and fat cake samples
were compared with mitochondrial samples of comparable optical
density on the radiograms. Integral density of regions of interest
(ROIs), measured with Image J 1.43u, was corrected for
background. The resulting value was regarded as indicator of the
amount of separated protein.325
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3372.6. Aldosterone production
For aldosterone experiments the cells were transfected by
means of electroporation on day 1 using either equal amounts of
three siRNA preparations for OPA1 (HSS107431, 107432 and
107433) or siRNA for Mfn1 (5141600) or a 1:1 mixture of non-
silencing RNA species with appropriate GC content (12935400
and 129305200). Following electroporation about 2.5  105 trans-
fected cells per sample were plated on a 24-well culture dish. The
cells were incubated in the tissue culture medium until the 2nd
(for 24-h stimulation) or 3rd day (for 2-h stimulation) when the
medium was replaced with 0.1% UltroSer G. Next day a 1-h prein-
cubation in serum-free medium was followed by a 2-h or 24-h
incubation in the serum-free medium, in the presence of appropri-
ate drugs. Aldosterone content of the incubation medium was
measured with Coat-A-Count RIA kit, for calibration synthetic aldo-
sterone was dissolved in cell-free incubation medium.Fig. 2. Confocal microscopic image of immunoreactive OPA1 and mitochondrially target
(left upper panel). The merged image is shown in the right upper panel. The arrows point
the arrowheads in the 2mt-eGFP panel. Intensity (arbitraty units) scanning of the line dra
of 21 cells. (For interpretation of the references to colour in this ﬁgure legend, the read
Please cite this article in press as: Fülöp, L., et al. Extramitochondrial OPA1 a
http://dx.doi.org/10.1016/j.mce.2013.07.0212.7. Measurement of cytosolic Ca2+ concentration
Cells transfected with Mfn1 or OPA1 siRNA were examined for
[Ca2+]c three days after transfection. Fluorescence of cells preload-
ed with Fluo 4 and MitoTracker Deep Red was monitored at room
temperature in multitrack mode with Zeiss LSM710 confocal laser
scanning microscope, operated with ZEN 11.0 software. The cells
were examined with a 63/1.4 oil immersion objective (Plan-Apo-
chromat, Zeiss). Transfection was regarded successful if mitochon-
dria showed fragmented pattern.
2.8. Protein determination
Protein content of cell samples was estimated with Bradford as-
say for aldosterone measurements and with BCA assay before SDS–
PAGE separations.
2.9. Statistics
Means + SEM are shown. For estimating signiﬁcance of differ-
ences unpaired t-test, factorial ANOVA and Tukey HSD test (Statis-
tica 11) were used.3. Results
3.1. Location of OPA1 in H295R cells
The intracellular location of OPA1 was ﬁrst examined in cells
transfected with mitochondrially targeted eGFP (2mt-eGFP). As
shown in Fig. 2, mitochondria were immunopositive for OPA1
and a few OPA1 spots could be found also out of the eGFP-labeleded eGFP in a H295R cell. OPA1 is shown in red (left lower panel), 2mt-eGFP in green
to extramitochondrial OPA1-positive spots. Note that no ﬂuorescence can be seen at
wn in the white frame is shown in right-hand lower panel. Representative for 10 out
er is referred to the web version of this article.)
nd adrenocortical function. Molecular and Cellular Endocrinology (2013),
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Fig. 3. Confocal microscopic image of cholesterol storing lipid droplets, immunoreactive OPA1 and the IMS-marker cytochrome c in a H295R cell. OPA1 is shown in red and
lipid droplets in green (left upper panel), cytochrome c in blue (left lower panel). The right-hand panel shows the merged image. The arrows point to extramitochondrial
OPA1-positive spots. Intensity (arbitraty units) scanning of the line drawn in the merged image is shown in the right lower panel. Note that no ﬂuorescence can be seen at the
arrowheads in the cytochrome c panel. (Line scanning was performed without prior deconvolution of the image.) Representative for 34 out of 96 cells. (For interpretation of
the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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3 August 2013particles. Altogether, emOPA1 could be detected in 10 out of 21
cells. In order to localize the presumed emOPA1 more precisely,
we applied triple staining. Cholesterol storing lipid droplets were
stained with the ﬂuorescent cholesterol-ester mimetic CholEste-
ryl-BODIPY FL C12, OPA1 was immunostained and IMS was labeled
with cytochrome c antibody. In average two emOPA1 immunopos-
itive spots have been detected in 34 cells. These spots were mostly
located in the vicinity of lipid droplets although OPA1 immunopo-
sitivity around the droplets predominantly colocalized with mito-
chondria (Fig. 3). emOPA1 could not be detected in another 62
cells. No OPA1 immunoreactivity was found after omitting the pri-
mary antibody (not shown). Examination with lambda scan mode
of confocal microscopy also revealed extramitochondrial immuno-
positive spots for OPA1 (Supplementary Fig. 1).370
371
372
373
374
375
3763.2. OPA1 in subcellular fractions
The homogenized cells were separated into three fractions by
differential centrifugation. Mitochondria were pelleted at 12,000
gmax  15 min. To obtain cytosol the supernatant was centifuged377
378
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387
Fig. 4. Western blot analysis of cell fractions. H295R cells were fractionated as
detailed in Section 2.4. OPA1 and the IMM-marker COX IV are shown. Represen-
tative for 3 cell fractionation studies.
Please cite this article in press as: Fülöp, L., et al. Extramitochondrial OPA1 a
http://dx.doi.org/10.1016/j.mce.2013.07.021at 31,000 gmax  25 min. A cloudy aggregate ﬂoating in the upper-
most layer of the cytosolic fraction was withdrawn and termed (in
analogy to fat cells) fat cake (Greenberg et al., 1991). The mito-
chondrial, cytosolic and fat cake fractions were analyzed for
OPA1 and the IMM-marker COX IV by Western blotting.
All three fractions contained OPA1 as well as COX IV (Fig. 4 and
Supplementary Table 2). In order to estimate mitochondrial con-
tamination, the ratio of OPA1 to COX IV was estimated for all three
fractions, taking this ratio in the mitochondrial fraction as unit. The
ratio increased in the cytosol over mitochondria by a factor of
11.5 ± 3.5 units (n = 3). Due to insufﬁcient amount of protein in
one experiment the ratio in the fat cake could be estimated only
in two fractionation studies where it attained 26.5 and 33.5 units.
These data indicate that the amount of OPA1 in the extramitochon-
drial fractions was more than attributable to mitochondrial con-
tamination (Supplementary Table 2).
The balance of the long (L) and short (S) isoforms of OPA1 in the
cytosolic fraction was shifted towards the short ones as compared
to that in the mitochondrial fraction. Whereas the S isoforms may
have originated from the IMS of mitochondria with damaged
OMM, L isoforms, which are anchored to the IMM (Delettre et al.,
2000; Lenaers et al., 2009; Liesa et al., 2009), may not have such
an origin. The contamination of the post-mitochondrial fractions
with cytochrome c (Supplementary Table 2) supports the assump-
tion that S isoforms may originate from damaged mitochondria.
3.3. Effect of OPA1 silencing on HSL phosphorylation
In order to test the presumed AKAP function of OPA1 we exam-
ined the knock-down of OPA1 on phosphorylation of HSL, a major
target of PKA. Exposing the cells to db-cAMP for 2 h brought about
a concentration dependent increase in the phosphorylated fraction
of the enzyme (p = 0.0009). Although the mean extent of phosphor-
ylation was somewhat lower in cells transfected with OPA1 siRNAnd adrenocortical function. Molecular and Cellular Endocrinology (2013),
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3 August 2013(Fig. 5 and Supplementary Fig. 2), the effect of silencing was not
statistically signiﬁcant (p = 0.19).
Next we examined whether angiotensin II-induced phosphory-
lation of HSL was dependent on OPA1. The hormone (1 nM) dou-
bled the formation of phospho-HSL. The knock-down of OPA1
was without effect (Fig. 5).
3.4. Effect of OPA1 silencing on cAMP-induced Ca2+ signaling
Eighty-ﬁve Mfn1-silenced cells and 52 OPA1-silenced cells were
stimulated with 0.05 mM db-cAMP. Most of the cells failed to re-
spond within 10 min. The evaluable response in 7 control cells
was almost thrice as high as that in 3 OPA1 – silenced cells; how-
ever, the number of responsive cells was too low for obtaining any
conclusion. When the cells were stimulated with 0.5 mM db-cAMP,
8 out of 42 Mfn1-silenced cells and 9 out of 39 OPA1-silenced cells
exhibited characteristic Ca2+ signal, with a lag-time between 4 and
10 min. Silencing failed to modify the amplitude of Ca2+ peaks
(Supplementary Fig. 3).
3.5. Effect of OPA1 silencing on aldosterone production
In order to ascertain whether emOPA1 exerts any effect on cho-
lesterol supply of steroid production we examined the effect of
OPA1 silencing on the PKA-dependent aldosterone production.
Considering that siRNA for OPA1 induces fragmentation of mito-
chondria (Olichon et al., 2003) and the consecutive changes in
mitochondrial volume/surface ratio might inﬂuence signaling pro-
cesses, comparison with maintained OPA1 expression but frag-
mented mitochondria were also required. Knock-down of Mfn1
also induces fragmentation without changes in the structure of
IMM (Arnoult et al., 2005; Eura et al., 2003). Transfection with siR-
NA for OPA1 in H295R cells efﬁciently reduced the expression of
OPA1 protein and did not inﬂuence that of Mfn1 protein (Fig. 1
in Fülöp et al., 2011) whereas transfection with siRNA for Mfn1 ex-
erted reciprocal effect (not shown). Knock-down of OPA1 andMfn1Please cite this article in press as: Fülöp, L., et al. Extramitochondrial OPA1 a
http://dx.doi.org/10.1016/j.mce.2013.07.021induce fragmentation with indistinguishable morphometric
changes (Figs. S1 and S3 in Fülöp et al., 2011) therefore, in addition
to the effect of transfection with scrambled RNA the effect of siRNA
against Mfn1 on hormone production has also been examined.
Aldosterone production has been studied under two different
conditions. During acute (2-h) stimulation with db-cAMP or angio-
tensin II hormone production depends on the activation of the
mechanism transporting cholesterol to the IMM. In contrast, dur-
ing long-term stimulation several proteins participating in hor-
mone production are also synthesized (Coulombe et al., 1996;
Hattangady et al., 2011; Spät and Hunyady, 2004). The greatly en-
hanced steroid production will then be much more dependent on
available free cholesterol.
Aldosterone response to db-cAMP or angiotensin II was exam-
ined in cells transfected with either control RNA or Mfn1 siRNA
or OPA1 siRNA. Each group was stimulated with either 0.05 or
0.5 mM db-cAMP or 1 nM angiotensin II for 2 h or with 0.5 mM
db-cAMP or 10 nM angiotensin II for 24 h. Qualitatively similar
aldosterone responses were measured in the short and long-term
stimulation series. db-cAMP stimulated aldosterone production
in each group in a concentration-dependent way. Comparison of
aldosterone production rates after transfection with various RNA
species showed that highest responses were attained in the
OPA1-silenced cells (for the effect of OPA1 siRNA: p = 104) (Fig. 6
and 7). Importantly, knock-down of OPA1 equally affected the re-
sponse to db-cAMP and angiotensin II, related to the effect of either
type of control transfection (Table 1). These measurements indi-
cate that the effect of OPA1 siRNA does not depend on the involve-
ment of PKA in the stimulation of aldosterone production.4. Discussion
Mitochondrial protein OPA1 located in close proximity with the
lipid droplets has recently been described in lipocytes (Pidoux
et al., 2011). Functioning as an AKAP it ampliﬁes the PKA-induced
phosphorylation of Plin 1, thus permitting enhanced lipolytic ac-nd adrenocortical function. Molecular and Cellular Endocrinology (2013),
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Fig. 6. Effect of knock-down of OPA1 on short-term aldosterone production. The
cells were transfected by means of electroporation with scrambled RNA or siRNA
against OPA1 or Mfn1 before plating. (Knock-down of Mfn1 evokes mitochondrial
fragmentation similar to the effect of siRNA for OPA1.) Three days later the cells
were stimulated with db-cAMP (0.05 or 0.5 mM) or angiotensin II (1 nM) for 2 h.
Mean + SEM of 6 experiments derived from 3 separate cell passages are shown. The
effect of agonists and that of RNA were highly signiﬁcant (ANOVA, p 106).
Highest aldosterone responses were attained in the OPA1-silenced cells (Tukey test,
p = 104).
Fig. 7. Effect of knock-down of OPA1 on long-term aldosterone production. The
cells were transfected as described for Fig. 6, however, two days after plating the
cells were stimulated with db-cAMP (0.5 mM) or angiotensin II (10 nM) for 24 h.
Mean + SEM of 6 experiments derived from 4 separate cell passages are shown. The
effect of agonists and that of RNA were highly signiﬁcant (ANOVA, p 106).
Highest aldosterone responses were attained in the OPA1-silenced cells (Tukey test,
p = 104).
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3 August 2013tion of HSL (Greenberg et al., 2011; Pidoux et al., 2011). HSL is a
major or sole factor responsible for cholesterol esterase activity
in steroid producing tissues including the adrenal cortex (Kraemer
et al., 2004). Plin 1 has been detected in a murine adrenocortical
cell line (Servetnick et al., 1995). In analogy to lipocytes (Brasaemle
et al., 2009; Sztalryd et al., 2003; Zhang et al., 2003) it can beTable 1
Aldosterone production by OPA1 – silenced cells, related to that by cells tran
Agonist 2 h
Control RNA Mfn1 s
0.05 mM db-cAMP 1.400 ± 0.138 1.340 ±
0.5 mM db-cAMP 1.580 ± 0.150 1.450 ±
1 nM angiotensin II 1.555 ± 0.128 1.514 ±
10 nM angiotensin II
Please cite this article in press as: Fülöp, L., et al. Extramitochondrial OPA1 a
http://dx.doi.org/10.1016/j.mce.2013.07.021hypothetised that also in adrenocortical cells, under control condi-
tions, Plin 1 forms a barrier at the surface of cholesterol ester con-
taining lipid droplets. Upon activation of PKA both HSL and Plin 1
undergo phosphorylation, the phosphorylated HSL docks to the
Plin 1 and gains access to cholesterol esters (Fig. 1). Presently no
data are available whether OPA1 exists in the cytosol of adrenocor-
tical cells and whether, functioning as an AKAP, it enhances cAMP-
induced aldosterone secretion.
When the cells are stimulated with a cAMP-mediated agonist,
PKA may enhance cholesterol supply of mitochondria primarily
by inducing and phosphorylating the cholesterol transporter StAR
and the translocator protein TSPO (Holysz et al., 2011; Midzak
et al., 2011). It may be assumed that without simulatenous activa-
tion of HSL StAR would function without substrate saturation. In
fact, PKA phosphorylates also HSL (Hirsch and Rosen, 1984). There-
fore HSL action on cytosolic cholesterol esters imported from the
extracellular ﬂuid as well as on those stored in lipid droplets (Hat-
tangady et al., 2011; Rone et al., 2009; Vinson et al., 1992) may
optimize cholesterol supply of mitochondria. Moreover, provided
data can be extrapolated from adipocytes (Miyoshi et al., 2006),
PKA phosphorylates perilipin and thereby facilitates the access of
activated HSL to its substrate. If OPA1 is present in the extramito-
chondrial space, due to its AKAP domain it could enhance most or
all of these processes. Moreover, even if HSL activity does not limit
hormone production, induction and activation of StAR is cAMP -
PKA dependent, therefore the elimination of the AKAP function
could still be reﬂected by attenuated cAMP - induced aldosterone
production.
As a ﬁrst approach to detect emOPA1 we applied immunocyto-
chemical technique, using laser scanning confocal microscopy. In
the ﬁrst series OPA1 was immunolabeled and mitochondria were
identiﬁed with mitochondrially targeted eGFP. In two further ser-
ies immunostaining was applied to OPA1 as well as to cytochrome
c, a mitochondrial marker located in the IMS whereas the lipid
droplets were stained with the cholesterol ester analogue Cho-
lEsteryl-BODIPY. The overwhelming majority of OPA1 positive
spots around the droplets colocalized with mitochondria. A few
emOPA1 immunopositive spots could also be found, mostly but
not exclusively in the vicinity of lipid droplets. Overall, nearly 40
per cent of cells displayed emOPA1 immunopositivity but the den-
sity of such signals was almost negligible. Therefore in spite of its
presence in the extramitochondrial space it was dubious whether
at such a low density in this space OPA1 can inﬂuence cholesterol
and thereby steroid metabolism.
Cell fractionation studies yielded similar results. Three fractions
were analyzed bymeans ofWestern blotting, themitochondrial and
cytosolic fractions as well as the uppermost layer of the cytosolic
fraction, termed fat cake. This latter fraction contained a ﬂoating
cloudy aggregate, probably corresponding to the lipid droplet-rich
fat cake in the cytosolic fraction of lipocytes (Greenberg et al.,
1991). Mitochondrial contamination of the post-mitochondrial
fractions was estimated on basis of their COX IV and cytochrome c
content, markers of IMM and IMS, respectively. The clear-cut
increase of OPA1/COX IV ratio in the cytosolic and fat cake
fractions indicated the presence of OPA1 in the extramitochondrial
compartment. The negligible amount of COX IV argues against thesfected with control RNA or Mfn1 siRNA.
24 h
iRNA Control RNA Mfn1 siRNA
0.131
0.114 1.367 ± 0.072 1.356 ± 0.076
0.094
1.289 ± 0.012 1.292 ± 0.063
nd adrenocortical function. Molecular and Cellular Endocrinology (2013),
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3 August 2013assumption that mitochondrial contamination is a major factor
accounting for the presence of OPA1 in the post-mitochondrial frac-
tions. Unexpectedly, the pattern of OPA1 isoforms in the mitochon-
drial fraction differed from that in the post-mitochondrial fractions,
being relatively enriched in short isoforms in the latter ones. Since
long isoforms are strongly attached to the IMM by their transmem-
brane domain whereas the short isoforms, lacking transmembrane
domain 1 (Song JCB 2007) are only weakly attached to membranes
(Satoh et al., 2003), the damage of the OMMmay lead to the leakage
of short isoforms only. (Note that only a small fraction of cyto-
chrome c is bound to membranes (Cortese et al., 1998), therefore
its leakage may exceed that of short OPA1 isoforms.) The presence
of cytochrome c in the cytosol supports the assumption that OMM
damage of variable extent may have occurred during cell
homogenization.
Since immunocytochemical and cell fractionation studies failed
to provide unambiguous indication for the signiﬁcance of emOPA1
we examined the effect of OPA1 siRNA on three PKA targets,
namely HSL, the cAMP-evoked Ca2+ signaling and aldosterone
production.
Two-hour stimulation with db-cAMP signiﬁcantly enhanced the
phosphorylation of HSL. Transfection with OPA1 siRNA was fol-
lowed by a slight, statistically insigniﬁcant decrease in the mean
value of phosphorylation. Angiotensin II-induced phosphorylation
of HSL, accounted for by Ca2+ dependent activation of CaMKII
(Cherradi et al., 1998) was not sensitive to OPA1 siRNA.
ACTH as well as 8-bromo-cAMP induce sustained Ca2+ response
after a lag-time of a few minutes in rat (Tremblay et al., 1991) and
human glomerulosa cells (Gallo-Payet et al., 1996). Similarly to
myocardiac cells (Sperelakis and Schneider, 1976) this effect of
cAMP in glomerulosa cells is brought about by the phosphorylation
of L-type Ca2+ channels by PKA (Durroux et al., 1991). It follows
that cAMP-induced Ca2+ signal could be regarded as an indicator
of OPA1 functioning as an extramitochondrial AKAP. db-cAMP-in-
duced Ca2+ signal in small fraction of the cells only. The signal
developed after a lag-time of several minutes and in quite a few
cases it was not substantial enough for reliable measurement.
For these reasons the effect of OPA1 silencing on the effect of
0.05 mM db-cAMP could not be conclusively evaluated. At a higher
concentration (0.5 mM) of the agonist, one third of the cells dis-
played Ca2+ signal and it was resistent to silencing of OPA1.
Irrespective of any effect of OPA1 on HSL in c-AMP acivated
cells, its presumed action on PKA should facilitate phosphorylation
and induction of StAR that in turn should lead to increased steroid
production. Moreover, the biological signiﬁcance of OPA1 in H295R
cells depends should be indicated on by its effect on aldosterone
secretion. Although aldosterone is one of several steroids produced
by H295R cells, all these steroids derive from the same cholesterol
pool and therefore aldosterone can be regarded as an appropriate
indicator of mitochondrial access to cholesterol. At designing the
experiments it had to be recalled that siRNA for OPA1 evokes frag-
mentation of mitochondria. In H295R cells the mitochondrion frag-
menting effect of Mfn1 siRNA is comparable with that of OPA1
siRNA (Fülöp et al., 2011), therefore cells transfected with siRNA
against Mfn1 were considered the appropriate control.
In principle, silencing of OPA1might exert a dual action on aldo-
sterone production, depending on the mode of action (cAMP or
Ca2+) of the physiological agonist. Although angiotensin II is a
Ca2+ mobilizing agonist and the action of ACTH is mediated by
cAMP, there is some overlap between their mode of action. Angio-
tensin II, acting via the heterotrimeric G-protein Gq (Gutowski
et al., 1991), induces acute aldosterone secretion by IP3-mediated
Ca2+ release (Enyedi et al., 1985), followed by Ca2+ inﬂux (Hunyady
et al., 1994; Kramer, 1988). The ensuing Ca2+ signal is a prerequi-
site for increased aldosterone secretion (Spät and Hunyady,
2004). ACTH or cAMP may also induce Ca2+ inﬂux and this Ca2+Please cite this article in press as: Fülöp, L., et al. Extramitochondrial OPA1 a
http://dx.doi.org/10.1016/j.mce.2013.07.021inﬂux contributes to the stimulation of aldosterone (Balla et al.,
1982). Ca2+ inﬂux may be attributed to PKA-enhanced activation
of L-type Ca2+ channels (Gallo-Payet et al., 1996; Lenglet et al.,
2002). db-cAMP-induced Ca2+ signals were observed also in the
present experiments. It follows that Ca2+ signaling may be a com-
mon element in the action of angiotensin II and cAMP. In contrast
to Ca2+ signaling, cAMP is not a common mediator of the two ago-
nists. In addition to Gq angiotensin II also activates the adenylyl cy-
clase inhibitory G protein Gi (Enyedi et al., 1986; Maturana et al.,
1999). This may be the reason why the peptide does not increase
the generation of cAMP (Bell et al., 1981; Hausdorff et al., 1987) de-
spite the probable expression (Tait and Tait, 1999) of Ca2+ sensitive
isoforms of adenylyl cyclase (Hanoune and Defer, 2001).
Cytosolic Ca2+ signal is transferred into the mitochondrial ma-
trix (Hajnóczky et al., 1995; Pralong et al., 1992; Rizzuto et al.,
1992) and the elevated mitochondrial [Ca2+] contributes to the
enhancement of steroid production (Spät et al., 2012; Wiederkehr
et al., 2011). Therefore changes in mitochondrial Ca2+ metabolism
should be considered at evaluating the effect of OPA1 knockdown
on aldosterone production. Applying the mitochondrially targeted
Ca2+-sensitive proteins 4mt-D2 and mt-inverse Pericam we ob-
served that knockdown of OPA1 signiﬁcantly enhanced mitochon-
drial Ca2+ uptake both in intact and permeabilized H295R and HeLa
cells (Fülöp et al., 2011). This enhancement was associated with in-
creased aldosterone production (Spät et al., 2012). Our data on
HeLa cells have not been conﬁrmed by Kushnareva et al. (2012)
who estimated [Ca2+]m with Rhod-2, a dye less speciﬁc for mito-
chondria than the mitochondrially targeted proteins applied in
our experiments. Alluding to the increased circularity (a parameter
indicating fragmentation) of mitochondria in the OPA1-silenced
cells (Fülöp et al., 2011) Kushnareva et al. attributed our results
to swelling of mitochondria. It should, however, be recalled that
we observed enhanced Ca2+ uptake also in comparison with
Mfn1-silenced cells, displaying circularity identical with that in
OPA1-silenced cells. Kushnareva et al. also reported that the num-
ber of Ca2+ pulses required to activate mitochondrial permeability
transition pore is less in OPA1-silenced cells than in sham-transfec-
ted controls. This observation may indicate enhanced rather than
attenuated Ca2+ uptake (cf. e.g. (Joiner et al., 2012; Mallilankar-
aman et al., 2012)). In addition to increased mitochondrial Ca2+ up-
take knock-down of OPA1 may enhance aldosterone production
also by enhanced cholesterol transport through the IMM into the
matrix, as observed in trophoblast cells (Wasilewski et al., 2012).
Again, in contrast to Ca2+ signaling, cAMP is not a common
intracellular mediator of ACTH and AII. Therefore, in OPA1-silenced
cells, due to the elimination of the presumed AKAP function, the
ampliﬁcation of secretory response to db-cAMP should be smaller
than in angiotensin II-stimulated cell. Nevertheless, this was not
the case. In fact, silencing of OPA1 the fold-response to all the stim-
uli increased in each group to the same extent, irrespective
whether PKA participated in the activation of steroid production.
This indicates that AKAP action of OPA1 has no role in the activa-
tion of cAMP-PKA mediated hormone production.
A special member of the AKAP family, AKAP121 can be an-
chored to mitochondria and may compartmentalize PKA as well
as other proteins on the OMM (Wong and Scott, 2004). In Leydig
cells, cAMP-induced StAR expression and steroidogenesis were
found to correlate with the extent of AKAP 121 expression (Dyson
et al., 2008). Expression and role of AKAP121 in H295R cells de-
serve elucidation.
In a recent review on OPA1 Belenguer and Pellegrini (Belenguer
and Pellegrini, 2012) emphasized the possibility that OPA1 re-
ported to be present in the lipid droplet fraction of adipocytes (Pi-
doux et al., 2011) may have been due to contamination with
mitochondria. These authors raised several questions concerning
the proposed role of OPA1 in lipolysis. Our observations supportnd adrenocortical function. Molecular and Cellular Endocrinology (2013),
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3 August 2013the presence of OPA1 in the extramitochondrial space, for the ﬁrst
time in a cell type other than adipocyte. At the same time we ob-
tained no evidence for the role of this fraction of OPA1 in cAMP-
mediated steroid hormone production, the speciﬁc biological func-
tion of adrenocortical cells.
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